Page 10 - Microarray Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mapping antibody reactivity in COVID-19 patients by using multi-coronavirus protein microarray
In an exciting, state-of-the-art study currently available on the
medRxiv preprint server, US researchers created a multi-coronavirus protein microarray containing full-length proteins, peptide libraries, and overlapping protein fragments from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as four other human coronaviruses. They demonstrated that this technology could be used for mapping antibody reactivity in coronavirus disease (COVID-19) patients.
Previous studies have demonstrated that patients with COVID-19 swiftly seroconvert to SARS-CoV-2, which means they produce Immunoglobulin IgA, IgG, and IgM antibodies directed against several viral proteins. Nonetheless, it is not completely clear whether all antibody responses are beneficial for us, or some can actually lead to a less favorable course of the disease. ....

United States , University Of California , Antigen Discovery Incorporated , Multi Coronavirus Protein , Image Credit , Corona Borealis Studio , Immunoglobulin Iga , Mayo Clinic , Corona Virus , Amino Acid , Coronavirus Disease Covid 19 , Immune Response , Mers Cov , Sars Cov 2 , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , படம் கடன் , கொரோனா போரியாலிஸ் ஸ்டுடியோ , மயோ சிகிச்சையகம் , கொரோனா வைரஸ் , அமினோ அமிலம் , நோய் எதிர்ப்பு சக்தி பதில் , மேற்ச் கோவ் , கடுமையானது எடுப்போசை சுவாச ,